NDC 71335-0171 – Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate

Dextroamphetamine Saccharate 2.5 mg/1; Amphetamine Aspartate 2.5 mg/1; Dextroamphetamine Sulfate 2.5 mg/1; Amphetamine Sulfate 2.5 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC71335-0171

Product details

Brand name
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Generic name
Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA040480
Marketed since
September 9, 2003
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (5)

Package NDCDescriptionSince
71335-0171-160 TABLET in 1 BOTTLE (71335-0171-1)Dec 27, 2021
71335-0171-230 TABLET in 1 BOTTLE (71335-0171-2)Feb 22, 2018
71335-0171-390 TABLET in 1 BOTTLE (71335-0171-3)Dec 27, 2021
71335-0171-4120 TABLET in 1 BOTTLE (71335-0171-4)Dec 27, 2021
71335-0171-518 TABLET in 1 BOTTLE (71335-0171-5)Dec 27, 2021

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products